NEW YORK (GenomeWeb) – Investment firm Innovatus Capital Partners said today that it has entered into a financing agreement with Personal Genome Diagnostics, providing up to $42 million in capital to support the company's efforts to advance in vitro diagnostics for genomic testing in cancer patients.

The investment firm didn't disclose further terms.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.